The Finish based publisher Global Research & Data Services has published several new reports concerning the market for construction machinery in 10 different European countries.

These market analyses give a clear overview of the actual situation and future outlook of the construction machinery market in the corresponding countries. The subjects discussed in the market analyses include:

(more…)

(more…)

(more…)

German auto major Volkswagen intends to hire around 1,300 workers by the end of 2010 at its Chakan manufacturing facility near Pune, India, reported Bloomberg.
The manufacturing plant, established with an investment of around $860 million, reportedly employs 1,200 workers.
According to the news source, the Chakan plant had begun production of Skoda Fabia hatchback in May 2009 and will commence production of Volkswagen Polo supermini car in the near future.

(more…)

Bayer Schering Pharma has announced the enrollment of first patients in an international clinical Phase III trial to evaluate the efficacy and safety of florbetaben PET imaging in the detection of beta-amyloid deposition in the brain.
(more…)

Results from two Phase III studies presented at the European Society for Medical Oncology Congress 2009 show statistically significant benefits via the addition of Vectibix to both first- and second-line chemotherapy for wild-type KRAS metastatic colorectal cancer. These positive data could help Vectibix to overcome Erbitux’s first-to-market status and usurp its current position.

The Phase III PRIME study investigated first-line FOLFOX4 (5-fluorouracil, leucovorin and oxaliplatin) with or without Vectibix (panitumumab; Amgen) in 1,183 metastatic colorectal cancer patients The addition of Vectibix to standard chemotherapy resulted in a statistically significant increase in progression-free survival of 9.6 months in wild-type KRAS patients, versus 8.0 months for chemotherapy alone (p=0.0234).

(more…)

US biotech Novavax has initiated a pivotal two-stage study for its H1N1 influenza vaccine in Mexico. Novavax’s strategy of pursuing approval for the vaccine in smaller markets before targeting the US represents an alternative and faster route to market. Given the many benefits of this strategy, Datamonitor believes that it may be adopted by other small vaccine companies in the future.
(more…)

Harley-Davidson is planning to divest its Italy-based MV Agusta unit and also discontinue the Buell motorcycles product line, as part of its go-forward business strategy to drive growth through a single-minded focus on the strengths of the Harley-Davidson brand.
(more…)

Global Research & Data Services has published 5 new registers concerning the medical device distributors in Russia, Finland, China, Germany and Sweden. Beside the company names this registers gives information about the products the different companies are distributing. Also it provides you with contact information as well as information concerning the contact person.
(more…)

The Pepsi Bottling Group has reported a net income attributable to the company of $254 million, or $1.14 per diluted share, for the third quarter ended September 5, 2009, compared to $231 million, or $1.06 per diluted share, for the third quarter ended September 6, 2008.
Net revenues for the third quarter of 2009 were $3.63 billion, compared to $3.81 billion in the same period of 2008.
(more…)